Fed. Circ. Affirms Illumina PTAB Wins Axing Columbia DNA IP
The Federal Circuit on Monday affirmed two split decisions by the Patent Trial and Appeal Board in favor of biotech company Illumina Inc. that found that claims in five Columbia University...To view the full article, register now.
Already a subscriber? Click here to view full article